用PROTAC对1类HDAC的向降解在诱导DLBCL细胞死亡方面非常有效
Abdullah Alraddadi1,2,3, Joshua P Smalley4, Wael Alzahrani1,2,3
1Mechanisms of Cancer and Aging Laboratory University of Leicester Leicester UK.
EJHaem
|August 13, 2025
概括
对于扩散性大B细胞淋巴瘤 (DLBCL) 需要新的向疗法. 一种新型的向嵌合体的蛋白质分解 (PROTAC) 通过诱导DNA损伤和亡,有效地杀死DLBCL细胞,提供了一个有前途的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 由于治疗耐药性和复发仍然具有挑战性.
- 目前的疗法有局限性,需要新的向策略.
- 基斯脱乙酶 (HDAC) 抑制剂显示出潜在的作用,但遭受非目标效应.
研究的目的:
- 研究针对DLBCL治疗的I类HDAC的新型向治疗方法.
- 为了评估一个PROTAC在DLBCL细胞中结合HDAC抑制剂和IAP配体的疗效.
主要方法:
- 使用一种向蛋白解的嵌合体 (PROTAC),结合HDAC抑制剂CI-994和IAP连接体.
- 评估了PROTAC对DLBCL细胞系的影响,包括细胞死亡,DNA损伤和亡诱导.
- 采用蛋白质组学来阐明作用机制.
主要成果:
- 在杀死DLBCL细胞系方面,PROTAC表现出显著的疗效,单独超过CI-994.
- 在DLBCL细胞中,PROTAC治疗诱导了DNA损伤和亡.
- 蛋白质组学揭示了同时激活亲亡蛋白和抑制亲生存途径.
结论:
- 使用特定的PROTACs对I类HDAC的有针对性的消除是DLBCL的一个精确和潜在的有效策略.
- 这种新型的PROTAC显示出在DLBCL治疗中进一步临床研究的希望.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Regulated Protein Degradation
7.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.6K
Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K


